To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TUG1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
456 supporting clones for gene TUG1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC037986 Uterus, leiomyosarcoma .a 1 to 2341 12 to 2353 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2342/2342
(100 %)
1 diff
(100.0 %id)
AK000625   .a 147 to 2341 1 to 2196 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2196/2196
(100 %)
2 diff
(100.0 %id)
TI_154122598   .a 741 to 1668 957 to 44       914/1074
(85 %)
27 diff
(97.5 %id)
TI_154110598   .a 753 to 1668 925 to 21       905/997
(90 %)
22 diff
(97.8 %id)
AK025129 colon .a 761 to 2359 1600 to 1   available from FLJ, Submitted on the opposite strand 1600/1944
(82 %)
2 diff
(99.9 %id)
BM721015 eye, fetal eye .a 788 to 1470 1 to 683       683/683
(100 %)
0 diff
(100 %id)
DB091480 testis .a 931 to 1484 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA117099 cerebellum .a 973 to 1511 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CB044441 colon, juvenile granulosa tumor .a 1005 to 1611 12 to 618     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 607/618
(98 %)
6 diff
(99.1 %id)
AW393917 testis .a 1034 to 1654 619 to 2       618/619
(99 %)
4 diff
(99.4 %id)
BG958922 colon .a 1044 to 1655 608 to 4       605/634
(95 %)
16 diff
(97.5 %id)
AW393931 testis .a 1070 to 1673 622 to 21       602/622
(96 %)
5 diff
(99.2 %id)
AW393924 testis .a 1084 to 1654 574 to 4       571/574
(99 %)
2 diff
(99.7 %id)
R84790 eye, retina .a 1298 to 1558 266 to 1     Submitted on the opposite strand 266/266
(100 %)
5 diff
(98.2 %id)
BM679445 eye, fetal eye .a 1664 to 2359 696 to 1       696/696
(100 %)
0 diff
(100 %id)
CB044440 colon, juvenile granulosa tumor .a 1739 to 2341 623 to 21   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 603/603
(100 %)
0 diff
(100 %id)
TI_157602615   .b 1 to 372 440 to 69   tiling clone,   372/969
(38 %)
0 diff
(100 %id)
DA808721 brain .b 173 to 737 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA857649 placenta .b 174 to 705 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA808374 brain .b 182 to 748 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AI186830 lung .b 359 to 901 1 to 543     Submitted on the opposite strand 543/543
(100 %)
0 diff
(100 %id)
BF064240 pooled .b 359 to 812 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
NR_002323.1   .b 359 to 7460 1 to 7102 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 7102/7102
(100 %)
1 diff
(100.0 %id)
CN395946 embryonic stem cells, DMSO-treated H9 cellline .b 367 to 629 268 to 6     Submitted on the opposite strand 263/268
(98 %)
0 diff
(100 %id)
BQ068117 brain .b 367 to 496 130 to 1     Submitted on the opposite strand 130/130
(100 %)
0 diff
(100 %id)
AI564355 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 392 to 805 1 to 414     Submitted on the opposite strand 414/414
(100 %)
0 diff
(100 %id)
AI352231   .b 402 to 755 1 to 354     Submitted on the opposite strand 354/354
(100 %)
0 diff
(100 %id)
DB225857 trachea .b 407 to 877 2 to 474   capped   473/473
(100 %)
2 diff
(99.6 %id)
BX645833   .b 432 to 908 1 to 477       477/477
(100 %)
1 diff
(99.8 %id)
CX753796 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 472 to 1200 1 to 729     Submitted on the opposite strand 729/730
(99 %)
3 diff
(99.6 %id)
AA885476 pooled .b 489 to 848 1 to 356     Submitted on the opposite strand 356/367
(97 %)
5 diff
(98.7 %id)
TI_154168309   .b 490 to 1067 80 to 662       583/988
(59 %)
58 diff
(94.2 %id)
AA210643   .b 619 to 856 11 to 247       237/247
(95 %)
6 diff
(97.6 %id)
DA122299 cerebellum .b 652 to 1205 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
AL120860 melanoma (MeWo cell line) .b 668 to 1088 1 to 421       421/421
(100 %)
0 diff
(100 %id)
CV571436 cornea, eye .b 700 to 1293 1 to 594       594/594
(100 %)
0 diff
(100 %id)
DA533998 brain .b 766 to 1322 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
TI_154152706   .b 943 to 1449 86 to 593       508/509
(99 %)
14 diff
(97.3 %id)
DA127128 cerebellum .b 989 to 1579 2 to 592   tiling clone, capped   591/591
(100 %)
0 diff
(100 %id)
EB385446 eye, optic nerve .b 1122 to 1916 1 to 795       795/795
(100 %)
1 diff
(99.9 %id)
AL706117 human skeletal muscle .b 1275 to 2009 1 to 735       735/735
(100 %)
3 diff
(99.6 %id)
DA029894   .b 1276 to 1846 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA489954 brain .b 1338 to 1863 2 to 527   capped   526/526
(100 %)
2 diff
(99.7 %id)
DA493844 brain .b 1375 to 1934 2 to 561   capped   560/569
(98 %)
3 diff
(99.5 %id)
AK056480   .b 1388 to 4131 1 to 2744 exact available from FLJ,   2744/2744
(100 %)
1 diff
(100.0 %id)
DA741880   .b 1389 to 1935 2 to 550   capped   549/549
(100 %)
3 diff
(99.5 %id)
DA489209 brain .b 1390 to 1930 2 to 543   capped   542/542
(100 %)
3 diff
(99.5 %id)
BF983075 duodenal adenocarcinoma, cell line, small intestine .b 1394 to 1941 1 to 548       548/548
(100 %)
3 diff
(99.5 %id)
DA442071 tongue, tumor tissue .b 1398 to 1951 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
AL700793 human skeletal muscle .b 1422 to 2049 1 to 628       628/628
(100 %)
1 diff
(99.9 %id)
AL699938 human skeletal muscle .b 1422 to 2049 1 to 628       628/628
(100 %)
1 diff
(99.9 %id)
BE870365 adenocarcinoma, colon .b 1422 to 2006 1 to 585       585/721
(81 %)
31 diff
(95.8 %id)
BE083970 breast .b 1426 to 1625 23 to 221       199/233
(85 %)
6 diff
(97.5 %id)
DA786708 brain .b 1428 to 2004 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA497037 brain .b 1430 to 2000 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA732500   .b 1430 to 2097 2 to 675   capped   674/674
(100 %)
13 diff
(98.1 %id)
DA783196 brain .b 1430 to 1984 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA331923 hippocampus .b 1431 to 1954 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
DA734634   .b 1433 to 2206 2 to 776   capped   775/776
(99 %)
11 diff
(98.6 %id)
DB167779 kidney, tumor tissue .b 1434 to 1984 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA504002 brain .b 1435 to 1994 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AA167682   .b 1443 to 2032 22 to 603       582/614
(94 %)
11 diff
(98.3 %id)
BE083407 breast .b 1540 to 2092 1 to 559       559/559
(100 %)
31 diff
(94.5 %id)
CN395943 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1549 to 2142 1 to 594       594/594
(100 %)
0 diff
(100 %id)
DA664338   .b 1559 to 2427 2 to 859   capped   858/862
(99 %)
17 diff
(98.1 %id)
BP240173 Liver .b 1566 to 2148 1 to 584       584/584
(100 %)
7 diff
(98.9 %id)
DA833087 placenta .b 1567 to 2375 2 to 819   capped   818/827
(98 %)
19 diff
(97.8 %id)
BP250806 hippocampus .b 1599 to 2179 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
AI290593 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1615 to 2097 488 to 3       486/488
(99 %)
0 diff
(100 %id)
AA748001 germinal center B cell .b 1628 to 2011 408 to 25   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 384/408
(94 %)
0 diff
(100 %id)
DN995183 brain, whole brain .b 1641 to 2404 1 to 768       768/827
(92 %)
13 diff
(98.5 %id)
BP229458 brain .b 1643 to 2228 1 to 585       585/585
(100 %)
4 diff
(99.4 %id)
DA577540   .b 1644 to 2165 2 to 525   capped   524/524
(100 %)
2 diff
(99.7 %id)
DA927990 small intestine .b 1668 to 2239 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
BP364282 lung .b 1719 to 2297 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA744934   .b 1721 to 2298 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA939694 Spleen .b 1728 to 2301 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA594352 lung .b 1745 to 2290 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA985245 synovial membrane tissue from rheumatioidarthritis .b 1752 to 2292 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BP207056 coronary artery .b 1888 to 2468 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA216175 brain .b 1936 to 2481 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AA554721 colon, tumor .b 2037 to 2450 1 to 414     Submitted on the opposite strand 414/414
(100 %)
0 diff
(100 %id)
DA744877   .b 2059 to 2628 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
TI_1948236401   .b 2237 to 2652 1013 to 590 D2A P6S D7K Q9P D10R ...   Submitted on the opposite strand 424/1251
(33 %)
16 diff
(98.8 %id)
TI_1948235932   .b 2240 to 2652 1013 to 592 D2E S3L R4Q F5I P6F ...   Submitted on the opposite strand 422/1268
(33 %)
18 diff
(98.6 %id)
TI_1948236400   .b 2240 to 2652 1021 to 600 L11R L13G E14K E16D C19F ...   Submitted on the opposite strand 422/1464
(28 %)
21 diff
(98.6 %id)
TI_1948235692   .b 2243 to 2652 1002 to 598     Submitted on the opposite strand 405/1441
(28 %)
29 diff
(98.0 %id)
TI_1948235931   .b 2243 to 2652 1003 to 602     Submitted on the opposite strand 402/1055
(38 %)
19 diff
(98.2 %id)
TI_1948236163   .b 2261 to 2652 1003 to 598     Submitted on the opposite strand 406/1315
(30 %)
24 diff
(98.2 %id)
TI_1948235693   .b 2301 to 2652 950 to 599     Submitted on the opposite strand 352/1249
(28 %)
12 diff
(99.1 %id)
BP280846   .b 2517 to 3099 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BM353997 Islets of Langerhans, Pancreas .b 2518 to 3082 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BM142215 Islets of Langerhans, Pancreas .b 2518 to 3078 1 to 561       561/561
(100 %)
0 diff
(100 %id)
AW175822 breast .b 2525 to 2680 158 to 3       156/158
(98 %)
0 diff
(100 %id)
BQ355260 head_neck .b 2566 to 2745 180 to 1       180/182
(98 %)
2 diff
(99.0 %id)
DB062143 testis .b 2578 to 3100 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DB076869 testis .b 2582 to 3129 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
FN097471 breast carcinoma .b 2643 to 2737 1 to 96       96/96
(100 %)
6 diff
(93.8 %id)
AW604129 colon .b 2749 to 3392 1 to 644       644/644
(100 %)
4 diff
(99.4 %id)
CB141510 Liver .b 2821 to 3403 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP240227 Liver .b 2823 to 3384 1 to 562       562/562
(100 %)
7 diff
(98.8 %id)
FN171535 breast carcinoma .b 2895 to 2990 97 to 1     Submitted on the opposite strand 97/97
(100 %)
4 diff
(95.9 %id)
DA832964 placenta .b 2916 to 3630 2 to 719   capped   718/719
(99 %)
9 diff
(98.8 %id)
DA096209 cerebellum .b 2918 to 3476 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BX643169   .b 2918 to 3534 1 to 617       617/617
(100 %)
0 diff
(100 %id)
FN102705 breast carcinoma .b 2949 to 3014 65 to 1     Submitted on the opposite strand 65/65
(100 %)
1 diff
(98.5 %id)
FN089436 breast carcinoma .b 3014 to 3111 98 to 1     Submitted on the opposite strand 98/98
(100 %)
0 diff
(100 %id)
AW373835 breast .b 3069 to 3414 361 to 13       349/371
(94 %)
1 diff
(99.8 %id)
DB070372 testis .b 3092 to 3627 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
FN105989 breast carcinoma .b 3134 to 3237 1 to 106       106/107
(99 %)
4 diff
(96.3 %id)
AW603939 colon .b 3219 to 3756 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
BM699745 eye, lens .b 3236 to 3619 1 to 385   fully sequenced,   385/385
(100 %)
0 diff
(100 %id)
DB282338 uterus .b 3243 to 3778 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DB159551 thymus .b 3246 to 3822 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB287395 uterus .b 3256 to 3803 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
L44407   .b 3281 to 3673 393 to 1       393/401
(98 %)
1 diff
(99.8 %id)
DA221813 brain .b 3284 to 3844 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CD628738   .b 3288 to 3492 213 to 8       206/219
(94 %)
0 diff
(100 %id)
TI_154167112   .b 3296 to 3756 81 to 541       461/461
(100 %)
0 diff
(100 %id)
TI_149303243   .b 3310 to 4155 882 to 49       834/1027
(81 %)
0 diff
(100 %id)
TI_149287567   .b 3341 to 4150 832 to 25       808/1248
(64 %)
0 diff
(100 %id)
FN113494 breast carcinoma .b 3348 to 3458 110 to 1     Submitted on the opposite strand 110/110
(100 %)
1 diff
(99.1 %id)
CV575312 cornea, eye .b 3378 to 3993 1 to 616       616/616
(100 %)
0 diff
(100 %id)
FN160118 breast carcinoma .b 3384 to 3502 117 to 1     Submitted on the opposite strand 117/117
(100 %)
2 diff
(98.3 %id)
BM981206 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 3449 to 4149 701 to 1       701/701
(100 %)
0 diff
(100 %id)
BF346364 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3457 to 4086 1 to 630       630/630
(100 %)
0 diff
(100 %id)
AB073661   .b 3468 to 6151 1 to 2685       2685/2686
(99 %)
3 diff
(99.9 %id)
AA167708   .b 3522 to 4135 603 to 1       603/629
(95 %)
14 diff
(97.8 %id)
DA019354   .b 3525 to 4082 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
FN072035 breast carcinoma .b 3525 to 3617 1 to 92       92/92
(100 %)
4 diff
(95.7 %id)
DB366758   .b 3551 to 4131 577 to 1       577/586
(98 %)
12 diff
(98.0 %id)
BM273072 Islets of Langerhans, Pancreas .b 3554 to 4134 581 to 1       581/581
(100 %)
2 diff
(99.7 %id)
CN484072 eye .b 3555 to 4150 595 to 1     Submitted on the opposite strand 595/595
(100 %)
1 diff
(99.9 %id)
BF845082 head_neck .b 3566 to 3915 348 to 1     Submitted on the opposite strand 348/348
(100 %)
4 diff
(98.9 %id)
BM142407 Islets of Langerhans, Pancreas .b 3573 to 4134 562 to 1       562/562
(100 %)
0 diff
(100 %id)
BF845092 head_neck .b 3580 to 3877 320 to 23     Submitted on the opposite strand 298/320
(93 %)
0 diff
(100 %id)
BU737565 eye, lens .b 3589 to 4149 561 to 1   fully sequenced,   561/561
(100 %)
0 diff
(100 %id)
BE348284 Kidney .b 3590 to 4133 544 to 1       544/544
(100 %)
0 diff
(100 %id)
DA228795 brain .b 3595 to 4153 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AW440289 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3595 to 4131 537 to 1       537/537
(100 %)
0 diff
(100 %id)
BG654734 Pancreas, Purified pancreatic islet .b 3605 to 4133 529 to 1     Submitted on the opposite strand 529/529
(100 %)
0 diff
(100 %id)
DB324753   .b 3610 to 4131 522 to 1       522/522
(100 %)
0 diff
(100 %id)
DB379651 placenta .b 3612 to 4131 517 to 1       517/538
(96 %)
17 diff
(96.9 %id)
AU144907 whole embryo, mainly head .b 3628 to 4131 509 to 1       509/509
(100 %)
8 diff
(98.5 %id)
AF088006   .b 3638 to 4266 1 to 629   AAA   629/672
(93 %)
4 diff
(99.5 %id)
BG059577 brain, glioblastoma without EGFR amplification .b 3638 to 4132 495 to 1       495/495
(100 %)
0 diff
(100 %id)
DB364012   .b 3649 to 4131 485 to 1       485/486
(99 %)
9 diff
(98.2 %id)
AI352455 pooled germ cell tumors .b 3651 to 4131 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BQ354237 head_neck .b 3656 to 3876 226 to 5       222/228
(97 %)
0 diff
(100 %id)
BG986438 head_neck .b 3660 to 3894 237 to 2       236/237
(99 %)
0 diff
(100 %id)
BG986539 head_neck .b 3660 to 3894 237 to 2       236/237
(99 %)
0 diff
(100 %id)
BF222723 pooled germ cell tumors .b 3670 to 4131 462 to 1       462/462
(100 %)
0 diff
(100 %id)
BE220983 carcinoid, lung .b 3671 to 4137 467 to 1       467/467
(100 %)
0 diff
(100 %id)
AI829442 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3686 to 4136 451 to 1       451/451
(100 %)
0 diff
(100 %id)
BF448445 skin, normal, 4 pooled samples .b 3686 to 4133 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI619772 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3715 to 4131 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI204502 lung .b 3731 to 4130 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AA811517 germinal center B cell .b 3733 to 4130 409 to 12   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
AA768156 germinal center B cell .b 3734 to 4130 407 to 11   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 397/397
(100 %)
0 diff
(100 %id)
BM042558 melanotic melanoma, cell line, skin .b 3753 to 4063 315 to 3       313/959
(32 %)
0 diff
(100 %id)
FN174869 breast carcinoma .b 3773 to 3871 1 to 98       98/98
(100 %)
1 diff
(99.0 %id)
AA876488 metastatic prostate bone lesion .b 3847 to 4139 294 to 1       294/298
(98 %)
2 diff
(99.4 %id)
DB147228 thymus .b 3874 to 4444 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
GD137808   .b 3929 to 4131 6 to 208   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 203/208
(97 %)
6 diff
(97.2 %id)
GD157879   .b 3929 to 4131 6 to 214   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 209/214
(97 %)
6 diff
(97.2 %id)
FN094363 breast carcinoma .b 3994 to 4100 1 to 110       110/110
(100 %)
3 diff
(97.3 %id)
FN052007 breast carcinoma .b 4010 to 4089 1 to 79       79/79
(100 %)
4 diff
(95.0 %id)
EC484806 Prostate .b 4019 to 4116 122 to 24       99/122
(81 %)
0 diff
(100 %id)
DB004483 breast, tumor tissue .b 4169 to 4727 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA595027 lung .b 4172 to 4753 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BM719085 eye, fetal eye .b 4176 to 4933 1 to 756     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 756/756
(100 %)
3 diff
(99.7 %id)
DA783990 brain .b 4192 to 4767 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB202420 trachea .b 4202 to 4768 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA115148 cerebellum .b 4212 to 4776 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA891472 rectum .b 4215 to 4773 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BU521207 leiomyosarcoma, uterus .b 4226 to 5106 1 to 890       890/894
(99 %)
21 diff
(97.7 %id)
DA439559 tongue, tumor tissue .b 4229 to 4814 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
D50525   .b 4232 to 6836 1310 to 3911       2602/2639
(98 %)
6 diff
(99.8 %id)
DA994929 synovial membrane tissue from rheumatioidarthritis .b 4255 to 4821 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
TI_154048098   .b 4319 to 4997 766 to 88   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 679/1007
(67 %)
0 diff
(100 %id)
DA452016 tongue, tumor tissue .b 4324 to 4897 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA790468 brain .b 4327 to 4865 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
AA770549 pooled .b 4336 to 4816 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
BQ926254 sciatic nerve .b 4352 to 5229 1 to 882       882/913
(96 %)
13 diff
(98.6 %id)
DA769869 brain .b 4378 to 4928 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA679891   .b 4414 to 4959 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BG991756 head_neck .b 4420 to 4565 143 to 1       143/146
(97 %)
7 diff
(95.3 %id)
BU620206 cell lines, Chondrosarcoma .b 4439 to 5001 581 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 563/563
(100 %)
0 diff
(100 %id)
DA641119 Liver .b 4447 to 4958 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
BE165922 head_neck .b 4498 to 4983 513 to 28     Submitted on the opposite strand 486/514
(94 %)
0 diff
(100 %id)
Z25210 leg muscle, skeletal muscle .b 4506 to 4842 1 to 337       337/337
(100 %)
4 diff
(98.9 %id)
DB379439 placenta .b 4509 to 5000 488 to 1       488/489
(99 %)
6 diff
(98.8 %id)
BQ023942 placenta .b 4534 to 5000 485 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 467/467
(100 %)
0 diff
(100 %id)
BU507913 leiomyosarcoma, uterus .b 4580 to 5703 1 to 1119       1119/1120
(99 %)
27 diff
(97.6 %id)
DB113820 thymus .b 4580 to 5151 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BM193667 leukopheresis .b 4587 to 5195 609 to 1       609/609
(100 %)
1 diff
(99.9 %id)
DB203062 trachea .b 4615 to 5189 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CX872680 embryonic stem .b 4621 to 5376 1 to 756       756/756
(100 %)
0 diff
(100 %id)
BF844737 head_neck .b 4632 to 5137 518 to 15     Submitted on the opposite strand 504/518
(97 %)
0 diff
(100 %id)
DA924800 small intestine .b 4644 to 5216 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB000811 breast, tumor tissue .b 4663 to 5205 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CX164404 human embryonic stem cells differentiated toan early endodermal cell type .b 4706 to 5554 1 to 849       849/849
(100 %)
0 diff
(100 %id)
BF361101 ovary .b 4709 to 5131 421 to 1       421/421
(100 %)
11 diff
(97.4 %id)
BM802559 embryonal carcinoma, cell line, testis .b 4717 to 5712 1 to 999       999/1118
(89 %)
24 diff
(97.9 %id)
TI_57180426   .b 4727 to 5530 35 to 838       804/838
(95 %)
6 diff
(99.3 %id)
DA937648 Spleen .b 4749 to 5334 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA999922 breast, tumor tissue .b 4755 to 5304 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BM144948 leukopheresis .b 4764 to 5195 432 to 1       432/435
(99 %)
5 diff
(98.9 %id)
CB119295 Liver .b 4765 to 5376 1 to 612       612/612
(100 %)
0 diff
(100 %id)
BG986250 head_neck .b 4781 to 5084 365 to 54       312/365
(85 %)
0 diff
(100 %id)
TI_57193445   .b 4817 to 5377 57 to 617       561/568
(98 %)
6 diff
(99.0 %id)
DA767497 tongue .b 4825 to 5412 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA140925 alzheimer cortex .b 4834 to 5475 2 to 643   capped   642/642
(100 %)
0 diff
(100 %id)
DA874624 Prostate .b 4835 to 5405 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA273677 corpus callosum .b 4839 to 5399 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CN420918 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 4849 to 5585 1 to 737       737/737
(100 %)
0 diff
(100 %id)
DB126532 thymus .b 4861 to 5434 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA377289 thalamus .b 4905 to 5467 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
CR623819 fetal brain .b 4911 to 6834 1 to 1924       1924/1924
(100 %)
0 diff
(100 %id)
DA468083   .b 4913 to 5486 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB270189 uterus .b 4913 to 5453 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BM193705 leukopheresis .b 4957 to 5195 240 to 1       240/264
(90 %)
19 diff
(92.9 %id)
CA430841 cell lines, Chondrosarcoma .b 4982 to 5668 706 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 688/688
(100 %)
1 diff
(99.9 %id)
CB152670 brain .b 4993 to 5591 1 to 599       599/599
(100 %)
0 diff
(100 %id)
TI_149274260   .b 5067 to 5641 60 to 634     Submitted on the opposite strand 575/1049
(54 %)
5 diff
(99.6 %id)
AI811146 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 5075 to 5519 1 to 445     Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
BF870390 lung_tumor .b 5088 to 5330 244 to 2     Submitted on the opposite strand 243/244
(99 %)
0 diff
(100 %id)
CB127883 cervix, Uterine .b 5105 to 5801 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
BQ215107 embryonal carcinoma, cell line, testis .b 5141 to 5892 1 to 755       755/894
(84 %)
4 diff
(99.6 %id)
CB216713 normal endometrium, mid-secretory phase,cycle day 23, uterus .b 5170 to 5724 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BQ293000 amnion_normal .b 5181 to 5479 304 to 1       304/304
(100 %)
17 diff
(94.5 %id)
FN092545 breast carcinoma .b 5217 to 5301 1 to 83       83/83
(100 %)
4 diff
(95.2 %id)
BF326406 amnion_normal .b 5223 to 5457 239 to 2       238/240
(99 %)
0 diff
(100 %id)
CV572999 cornea, eye .b 5266 to 5857 1 to 592       592/592
(100 %)
0 diff
(100 %id)
TI_57202545   .b 5267 to 6044 62 to 837       776/837
(92 %)
6 diff
(99.3 %id)
DA835438 placenta .b 5275 to 5800 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
TI_57177806   .b 5308 to 6208 73 to 979       907/979
(92 %)
6 diff
(99.4 %id)
DA358057 subthalamic nucleus .b 5320 to 5900 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA689774   .b 5320 to 5856 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BM683055 eye, fetal eye .b 6243 to 6911 686 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 668/668
(100 %)
1 diff
(99.9 %id)
DA737185   .c 1 to 880 2 to 881 L32F F33L L34F N35L F36N ... tiling clone, capped   880/883
(99 %)
10 diff
(98.9 %id)
CR456447   .c 401 to 865 1 to 464 exact     464/464
(100 %)
1 diff
(99.8 %id)
BF905690 marrow .c 411 to 812 400 to 2     Submitted on the opposite strand 399/400
(99 %)
0 diff
(100 %id)
DA569016 whole embryo, mainly head .c 458 to 1248 2 to 793 exact tiling clone, capped   792/792
(100 %)
6 diff
(99.3 %id)
CU013333 Synthetic constructs .c 480 to 817 18 to 355       338/370
(91 %)
7 diff
(98.2 %id)
CU013045 Synthetic constructs .c 480 to 822 18 to 360 exact     343/373
(91 %)
6 diff
(98.4 %id)
DB369770   .c 1719 to 2301 584 to 4   tiling clone,   581/590
(98 %)
0 diff
(100 %id)
DB355601 whole embryo, mainly head .c 1749 to 2303 556 to 1   tiling clone,   556/557
(99 %)
13 diff
(97.7 %id)
CA420106 Bone, Human Chondrosarcoma Cell Line .d 1 to 630 645 to 17 exact tiling clone, AAA   629/629
(100 %)
1 diff
(99.9 %id)
BF834073 head_neck .d 120 to 638 19 to 555 F5S E16R R17K A18S C19L ...     537/559
(96 %)
34 diff
(94.0 %id)
DA266269 caudate nucleus .d 145 to 700 2 to 557 S68P capped   556/556
(100 %)
1 diff
(99.9 %id)
BP216461 corpus callosum .d 216 to 798 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA789829 brain .d 333 to 917 2 to 587   tiling clone, capped   586/586
(100 %)
1 diff
(99.9 %id)
BQ028084 mixed .d 509 to 744 250 to 16   AAA   235/235
(100 %)
1 diff
(99.6 %id)
CN298759 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 846 to 1457 1 to 612   tiling clone,   612/612
(100 %)
0 diff
(100 %id)
BP241029 Liver .d 865 to 1441 1 to 577       577/577
(100 %)
6 diff
(99.0 %id)
BP241042 Liver .d 865 to 1441 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
BP241473 Liver .d 865 to 1433 1 to 569       569/569
(100 %)
8 diff
(98.6 %id)
BU153801 eye, retinoblastoma .d 967 to 1594 12 to 647       636/834
(76 %)
13 diff
(98.5 %id)
N39633 melanocyte .d 1167 to 1519 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
DR421686 eye, Pterygium .d 1322 to 1836 1 to 515   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 515/515
(100 %)
3 diff
(99.5 %id)
FN140830 breast carcinoma .d 1366 to 1447 90 to 5     Submitted on the opposite strand 86/91
(94 %)
0 diff
(100 %id)
AW075446 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 1439 to 1837 398 to 1   tiling clone,   398/398
(100 %)
2 diff
(99.5 %id)
BM475444 eye, retinoblastoma .d 1464 to 2130 1 to 668   tiling clone,   668/1113
(60 %)
3 diff
(99.8 %id)
AA554572 colon, tumor .d 1557 to 1835 279 to 1       279/279
(100 %)
0 diff
(100 %id)
DA149995 amygdala .d 1656 to 2233 2 to 582   capped   581/582
(99 %)
5 diff
(99.2 %id)
BQ879970 dorsal root ganglia .d 1660 to 2486 1 to 835       835/851
(98 %)
13 diff
(98.5 %id)
FN152085 breast carcinoma .d 1680 to 1757 1 to 76       76/76
(100 %)
3 diff
(96.1 %id)
DT217446 brain .d 1784 to 2434 1 to 651   tiling clone,   651/651
(100 %)
0 diff
(100 %id)
DA572726 whole embryo, mainly body .d 1790 to 2625 2 to 835   capped   834/845
(98 %)
12 diff
(98.6 %id)
DA568566 whole embryo, mainly head .d 1944 to 2665 2 to 723   capped   722/722
(100 %)
2 diff
(99.8 %id)
DB097540 testis .d 1967 to 2432 2 to 467   capped   466/466
(100 %)
0 diff
(100 %id)
AW754383 colon .d 2019 to 2526 1 to 508       508/514
(98 %)
9 diff
(98.3 %id)
FN157680 breast carcinoma .d 2030 to 2132 103 to 1     Submitted on the opposite strand 103/103
(100 %)
0 diff
(100 %id)
W24613 lung .d 2040 to 2469 1 to 433       433/433
(100 %)
4 diff
(99.1 %id)
CA396701 eye, RPE/choroid .d 2090 to 2572 1 to 483       483/483
(100 %)
0 diff
(100 %id)
FN053492 breast carcinoma .d 2113 to 2196 95 to 10     Submitted on the opposite strand 86/95
(90 %)
0 diff
(100 %id)
FN177071 breast carcinoma .d 2271 to 2349 1 to 79       79/79
(100 %)
2 diff
(97.5 %id)
FN177450 breast carcinoma .d 2271 to 2330 1 to 59       59/59
(100 %)
1 diff
(98.4 %id)
CN298760 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 2285 to 3001 12 to 728       717/728
(98 %)
6 diff
(99.2 %id)
CB115800 Liver .d 2306 to 2828 1 to 523       523/523
(100 %)
0 diff
(100 %id)
CB120489 Liver .d 2306 to 2821 1 to 516       516/516
(100 %)
1 diff
(99.9 %id)
BM456699 lymph, lymphoma, cell line .d 2356 to 3214 1 to 866   tiling clone,   866/942
(91 %)
15 diff
(98.5 %id)
AA149018 colon, tumor .d 2385 to 2789 1 to 405       405/406
(99 %)
1 diff
(99.8 %id)
DB086365 testis .d 2500 to 3047 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BQ716414 sympathetic trunk .d 2552 to 3109 1 to 565       565/1228
(46 %)
20 diff
(98.4 %id)
BG005857 placenta_normal .d 2576 to 2913 26 to 358       333/368
(90 %)
10 diff
(97.3 %id)
DB359807 whole embryo, mainly body .d 3006 to 3552 551 to 1       551/555
(99 %)
11 diff
(98.1 %id)
DB301664 amygdala .d 3020 to 3552 534 to 1   tiling clone,   534/534
(100 %)
1 diff
(99.9 %id)
DB355086 whole embryo, mainly head .d 3041 to 3552 510 to 2       509/514
(99 %)
0 diff
(100 %id)
AA149019 colon, tumor .d 3129 to 3552 424 to 1   tiling clone,   424/424
(100 %)
2 diff
(99.6 %id)
AW393919 testis .e 1 to 390 1 to 391 Q2R S4A A5G I6S V7R ... tiling clone,   391/391
(100 %)
12 diff
(97.0 %id)
AW393925 testis .e 24 to 390 1 to 364   tiling clone,   364/364
(100 %)
7 diff
(98.1 %id)
AW393922 testis .e 31 to 390 1 to 358       358/358
(100 %)
2 diff
(99.5 %id)
AW393936 testis .e 33 to 390 1 to 358   tiling clone,   358/358
(100 %)
1 diff
(99.8 %id)
AW393937 testis .e 51 to 390 1 to 340       340/340
(100 %)
2 diff
(99.5 %id)
BU431727 lymph .f 1 to 443 8 to 450 exact     443/450
(98 %)
6 diff
(98.7 %id)
TI_154153735   .f 1 to 498 80 to 577 exact tiling clone,   498/499
(99 %)
2 diff
(99.6 %id)
BU431471 lymph .f 2 to 371 9 to 378 exact     370/378
(97 %)
9 diff
(97.7 %id)
TI_154153385   .f 2 to 601 81 to 679 exact tiling clone,   599/600
(99 %)
23 diff
(96.2 %id)
AK000749   .g 1 to 2110 1 to 2112 exact tiling clone, available from FLJ,   2112/2112
(100 %)
8 diff
(99.7 %id)
BP295275   .g 511 to 1091 1 to 581   tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
BP207855 coronary artery .h 1 to 574 1 to 574 exact tiling clone,   574/574
(100 %)
3 diff
(99.5 %id)
DA779858 brain .i 1 to 578 2 to 579   tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
CN395945 embryonic stem cells, DMSO-treated H9 cellline .i 144 to 526 1 to 383       383/383
(100 %)
1 diff
(99.8 %id)
BQ378435 uterus_tumor .i 174 to 503 10 to 344       335/344
(97 %)
18 diff
(94.8 %id)
BE765640 nervous_tumor .i 181 to 514 1 to 334       334/336
(99 %)
4 diff
(98.9 %id)
BE765641 nervous_tumor .i 181 to 514 1 to 334       334/336
(99 %)
3 diff
(99.2 %id)
AW967782   .i 291 to 795 1 to 506       506/506
(100 %)
9 diff
(98.3 %id)
AA262264 germinal center B cell .i 291 to 729 1 to 439     Submitted on the opposite strand 439/439
(100 %)
0 diff
(100 %id)
AA252615 germinal center B cell .i 296 to 638 1 to 343     Submitted on the opposite strand 343/343
(100 %)
0 diff
(100 %id)
CV402641 breast_normal .i 322 to 503 107 to 289       241/289
(83 %)
16 diff
(94.5 %id)
CN292004 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 463 to 1189 1 to 728       728/730
(99 %)
5 diff
(99.4 %id)
DA373950 thalamus .i 486 to 909 2 to 425   capped   424/424
(100 %)
1 diff
(99.8 %id)
DA257586 caudate nucleus .i 487 to 1049 2 to 564   tiling clone, capped   563/563
(100 %)
0 diff
(100 %id)
DB113132 thymus .i 573 to 1133 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BU584944 colon tumor .i 822 to 1215 1 to 394       394/395
(99 %)
1 diff
(99.8 %id)
DA422023 cervix .i 840 to 1433 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
AK057695   .i 921 to 3154 1 to 2234   tiling clone, available from FLJ,   2234/2234
(100 %)
1 diff
(100.0 %id)
DB246839   .i 922 to 1418 2 to 499   capped   498/498
(100 %)
1 diff
(99.8 %id)
R58047   .i 1072 to 1219 1 to 146       146/151
(96 %)
7 diff
(95.4 %id)
AA249357   .i 1110 to 1453 8 to 350       343/350
(98 %)
6 diff
(98.3 %id)
EH350881   .i 1250 to 1321 1 to 72       72/72
(100 %)
0 diff
(100 %id)
CB410316 maxilla, pooled .i 1322 to 1745 13 to 436     Submitted on the opposite strand 424/436
(97 %)
6 diff
(98.7 %id)
CB410317 maxilla, pooled .i 1322 to 1745 424 to 1     Submitted on the opposite strand 424/436
(97 %)
7 diff
(98.4 %id)
DT217521 brain .i 1333 to 1988 1 to 656       656/656
(100 %)
1 diff
(99.9 %id)
DA800307 brain .i 1340 to 1912 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
AU253843 neuroblastoma .i 1394 to 2034 1 to 641       641/641
(100 %)
2 diff
(99.7 %id)
DA728181   .i 1480 to 2143 2 to 666   capped   665/675
(98 %)
2 diff
(99.8 %id)
DB350716   .i 2611 to 3154 544 to 1       544/544
(100 %)
1 diff
(99.9 %id)
DA062713 cerebellum .j-u 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
DA540950 lung .j-u 2 to 587 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
BM739132 Ascites, stomach .j-u 10 to 544 1 to 535       535/535
(100 %)
0 diff
(100 %id)
FN078150 breast carcinoma .j-u 33 to 133 99 to 1     Submitted on the opposite strand 99/101
(98 %)
3 diff
(97.1 %id)
FN166847 breast carcinoma .j-u 33 to 128 1 to 95       95/101
(94 %)
2 diff
(98.1 %id)
BG572349 placenta .j-u 46 to 802 1 to 757       757/758
(99 %)
6 diff
(99.3 %id)
TI_154188199   .j-u 67 to 960 118 to 1007       890/928
(95 %)
39 diff
(95.8 %id)
BM764486 stomach .j-u 69 to 786 1 to 718       718/718
(100 %)
0 diff
(100 %id)
BM765961 stomach .j-u 69 to 559 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BM771592 stomach .j-u 69 to 786 1 to 718       718/718
(100 %)
0 diff
(100 %id)
BG618379 Liver .j-u 81 to 921 1 to 849       849/849
(100 %)
26 diff
(97.0 %id)
CN370703 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j-u 128 to 795 1 to 668       668/668
(100 %)
0 diff
(100 %id)
FN062678 breast carcinoma .j-u 136 to 212 77 to 1     Submitted on the opposite strand 77/78
(98 %)
0 diff
(100 %id)
BM468664 leiomyosarcoma, uterus .j-u 137 to 1127 1 to 999       999/1075
(92 %)
35 diff
(96.8 %id)
BM557055 melanotic melanoma, skin .j-u 149 to 1193 1 to 1042       1042/1046
(99 %)
24 diff
(97.8 %id)
CD677006 eye, Trabecular meshwork .j-u 180 to 789 1 to 610       610/610
(100 %)
0 diff
(100 %id)
BG005799 placenta_normal .j-u 188 to 777 590 to 1       590/590
(100 %)
2 diff
(99.7 %id)
EL947028 eyeball .j-u 198 to 478 41 to 323       283/323
(87 %)
6 diff
(98.2 %id)
BF880848 lung_tumor .j-u 238 to 765 541 to 14     Submitted on the opposite strand 528/541
(97 %)
0 diff
(100 %id)
BE932213 head_neck .j-u 245 to 700 456 to 1       456/456
(100 %)
3 diff
(99.4 %id)
AI110588 Liver .j-u 265 to 642 378 to 1       378/595
(63 %)
0 diff
(100 %id)
CD514605 White Matter .j-u 303 to 1146 1 to 844       844/847
(99 %)
1 diff
(99.9 %id)
BI044558 ovary .j-u 327 to 767 449 to 8       442/449
(98 %)
0 diff
(100 %id)
AA834574 germinal center B cell .j-u 335 to 742 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AA847170 germinal center B cell .j-u 355 to 798 446 to 3       444/446
(99 %)
0 diff
(100 %id)
BQ337499 marrow .j-u 360 to 779 437 to 26       412/437
(94 %)
0 diff
(100 %id)
AA252802 germinal center B cell .j-u 380 to 791 412 to 1       412/412
(100 %)
0 diff
(100 %id)
BF851506 lung_normal .j-u 387 to 781 397 to 3     Submitted on the opposite strand 395/397
(99 %)
0 diff
(100 %id)
BM728560 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j-u 403 to 1144 1 to 739       739/739
(100 %)
5 diff
(99.4 %id)
DR421777 eye, Pterygium .j-u 408 to 985 1 to 578       578/578
(100 %)
0 diff
(100 %id)
AW753218 colon .j-u 413 to 961 551 to 1       551/551
(100 %)
7 diff
(98.8 %id)
BM705871 eye, lens .j-u 413 to 769 1 to 357     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
CR594262 Placenta Cot 25-normalized .j-u 419 to 1557 1 to 1139   tiling clone,   1139/1139
(100 %)
0 diff
(100 %id)
BG003695 placenta_normal .j-u 445 to 759 318 to 3       316/318
(99 %)
0 diff
(100 %id)
BM789988 stomach .j-u 516 to 1207 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
BY797196 eye .j-u 521 to 1141 621 to 1     Submitted on the opposite strand 621/621
(100 %)
0 diff
(100 %id)
BQ631820 Pancreas, Purified pancreatic islet .j-u 542 to 1051 1 to 510       510/510
(100 %)
0 diff
(100 %id)
TI_154107414   .j-u 555 to 1555 1096 to 93   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1004/1006
(99 %)
49 diff
(95.2 %id)
CA867677 Pancreas, Purified pancreatic islet .j-u 556 to 1081 2 to 527   fully sequenced,   526/527
(99 %)
5 diff
(99.1 %id)
BF822687 kidney_tumor .j-u 582 to 858 272 to 1     Submitted on the opposite strand 272/272
(100 %)
6 diff
(97.8 %id)
BU785703 Pancreas, Purified pancreatic islet .j-u 589 to 1078 1 to 490   fully sequenced,   490/490
(100 %)
0 diff
(100 %id)
CV574621 cornea, eye .j-u 596 to 1220 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
AW992357 breast_normal .j-u 633 to 1104 484 to 1     Submitted on the opposite strand 484/484
(100 %)
9 diff
(98.2 %id)
BF950346 nervous_normal .j-u 665 to 938 279 to 6       274/279
(98 %)
0 diff
(100 %id)
CK903894 Islets of Langerhans, Pancreas .j-u 669 to 1254 1 to 586       586/586
(100 %)
0 diff
(100 %id)
TI_149293474   .j-u 678 to 1560 952 to 91   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 862/972
(88 %)
29 diff
(97.1 %id)
BM052932 Islets of Langerhans, Pancreas .j-u 685 to 1238 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BM053017 Islets of Langerhans, Pancreas .j-u 685 to 1122 1 to 438   fully sequenced,   438/438
(100 %)
0 diff
(100 %id)
W88638 liver and spleen .j-u 686 to 1144 1 to 459       459/459
(100 %)
0 diff
(100 %id)
AW373523 breast .j-u 700 to 1331 629 to 4       626/629
(99 %)
0 diff
(100 %id)
TI_154059070   .j-u 703 to 1560 919 to 79   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 841/1013
(83 %)
23 diff
(97.8 %id)
BE146085 head_neck .j-u 711 to 1145 469 to 35     Submitted on the opposite strand 435/482
(90 %)
0 diff
(100 %id)
TI_149298332   .j-u 712 to 1555 935 to 85   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 851/942
(90 %)
30 diff
(96.9 %id)
TI_149272738   .j-u 715 to 1555 919 to 84   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 836/996
(83 %)
27 diff
(97.3 %id)
W95447 heart .j-u 716 to 1177 1 to 462   fully sequenced,   462/462
(100 %)
0 diff
(100 %id)
TI_154097079   .j-u 729 to 1555 903 to 88   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 816/820
(99 %)
17 diff
(98.0 %id)
CA315026 Human Lung Epithelial cells, lung .j-u 730 to 1555 840 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 822/822
(100 %)
6 diff
(99.3 %id)
AA429541   .j-u 747 to 1236 1 to 490   fully sequenced,   490/490
(100 %)
0 diff
(100 %id)
TI_149307739   .j-u 750 to 1560 882 to 92   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 791/940
(84 %)
27 diff
(97.2 %id)
BM806212 leiomyosarcoma, uterus .j-u 753 to 1557 1 to 806       806/1086
(74 %)
4 diff
(99.7 %id)
AA022548 heart .j-u 762 to 877 1 to 116       116/116
(100 %)
0 diff
(100 %id)
TI_149293676   .j-u 782 to 1555 849 to 87   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 763/974
(78 %)
14 diff
(98.6 %id)
TI_159714908   .j-u 785 to 1560 849 to 84   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 766/964
(79 %)
12 diff
(98.8 %id)
TI_151758129   .j-u 805 to 1555 847 to 84   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 764/771
(99 %)
29 diff
(96.3 %id)
CN293243 embryonic stem cells, DMSO-treated H9 cellline .j-u 807 to 1421 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BQ448296 Knee, Osteoarthritic Cartilage .j-u 823 to 1555 747 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 729/738
(98 %)
3 diff
(99.6 %id)
BQ576280 Chondrosarcoma Grade II, Left Pelvis .j-u 827 to 1555 747 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 729/729
(100 %)
3 diff
(99.6 %id)
BE940571 uterus_tumor .j-u 828 to 1152 325 to 1       325/325
(100 %)
2 diff
(99.4 %id)
BF907875 uterus_tumor .j-u 828 to 1153 327 to 2     Submitted on the opposite strand 326/327
(99 %)
0 diff
(100 %id)
BF908503 uterus_tumor .j-u 828 to 1153 327 to 2     Submitted on the opposite strand 326/327
(99 %)
0 diff
(100 %id)
FN138084 breast carcinoma .j-u 856 to 945 1 to 89       89/89
(100 %)
3 diff
(96.7 %id)
FN154620 breast carcinoma .j-u 856 to 943 1 to 88       88/89
(98 %)
2 diff
(97.8 %id)
BM975213 lung .j-u 858 to 1555 713 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 695/695
(100 %)
5 diff
(99.3 %id)
AA486695 lung .j-u 865 to 1169 1 to 307   fully sequenced,   307/307
(100 %)
0 diff
(100 %id)
TI_154042965   .j-u 877 to 1555 760 to 84   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 677/1019
(66 %)
3 diff
(99.8 %id)
FN114428 breast carcinoma .j-u 880 to 951 72 to 1     Submitted on the opposite strand 72/73
(98 %)
0 diff
(100 %id)
BQ006594 Chondrosarcoma, Left Pelvis .j-u 884 to 1555 688 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 670/670
(100 %)
2 diff
(99.8 %id)
CA440622 Chondrosarcoma, Left Pubic Bone .j-u 887 to 1555 685 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 667/667
(100 %)
2 diff
(99.8 %id)
AW389287 stomach .j-u 897 to 1134 238 to 1       238/238
(100 %)
0 diff
(100 %id)
AW935198 denis_drash .j-u 904 to 1513 616 to 14     Submitted on the opposite strand 603/633
(95 %)
0 diff
(100 %id)
BI000899 head_normal .j-u 905 to 1065 157 to 1       157/157
(100 %)
6 diff
(96.2 %id)
EL948114 eyeball .j-u 924 to 1560 1 to 637   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 637/637
(100 %)
4 diff
(99.4 %id)
CB241641 Human Lung Epithelial cells, lung .j-u 949 to 1560 630 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 612/621
(98 %)
0 diff
(100 %id)
AW170564 cervix, tumor .j-u 951 to 1557 607 to 1       607/607
(100 %)
0 diff
(100 %id)
AA074901   .j-u 956 to 1290 1 to 339   fully sequenced,   339/339
(100 %)
0 diff
(100 %id)
AI872395 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j-u 959 to 1560 629 to 28   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 602/602
(100 %)
0 diff
(100 %id)
BE156375 head_neck .j-u 974 to 1313 349 to 12     Submitted on the opposite strand 338/349
(96 %)
0 diff
(100 %id)
CK903893 Islets of Langerhans, Pancreas .j-u 976 to 1557 586 to 5       582/586
(99 %)
0 diff
(100 %id)
EL946046 eyeball .j-u 977 to 1407 1 to 430       430/430
(100 %)
7 diff
(98.4 %id)
BM718266 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j-u 997 to 1560 1 to 564   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 564/564
(100 %)
0 diff
(100 %id)
BE159301 head_neck .j-u 1011 to 1175 171 to 2     Submitted on the opposite strand 170/171
(99 %)
0 diff
(100 %id)
BE159319 head_neck .j-u 1011 to 1175 171 to 2     Submitted on the opposite strand 170/171
(99 %)
0 diff
(100 %id)
BM667847 eye, lens .j-u 1014 to 1555 560 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 542/542
(100 %)
0 diff
(100 %id)
BG656397 Pancreas, Purified pancreatic islet .j-u 1018 to 1550 538 to 5     Submitted on the opposite strand 534/538
(99 %)
0 diff
(100 %id)
AV720399 corresponding non cancerous liver tissue .j-u 1031 to 1554 524 to 1     Submitted on the opposite strand 524/524
(100 %)
2 diff
(99.7 %id)
BM052672 Islets of Langerhans, Pancreas .j-u 1036 to 1557 526 to 5       522/526
(99 %)
0 diff
(100 %id)
BE464666 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .j-u 1046 to 1555 510 to 1       510/510
(100 %)
0 diff
(100 %id)
BU785399 Pancreas, Purified pancreatic islet .j-u 1048 to 1555 508 to 1   fully sequenced,   508/508
(100 %)
0 diff
(100 %id)
BP388312 pancreatic islet .j-u 1049 to 1553 1 to 505     Submitted on the opposite strand 505/505
(100 %)
0 diff
(100 %id)
CA867396 Pancreas, Purified pancreatic islet .j-u 1051 to 1555 505 to 1   fully sequenced,   505/505
(100 %)
0 diff
(100 %id)
BP398827 pancreatic islet .j-u 1056 to 1555 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BP387466 pancreatic islet .j-u 1063 to 1557 1 to 495     Submitted on the opposite strand 495/497
(99 %)
1 diff
(99.8 %id)
AI923075 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .j-u 1066 to 1559 494 to 1       494/494
(100 %)
0 diff
(100 %id)
AA687272 germinal center B cell .j-u 1083 to 1555 484 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 473/473
(100 %)
0 diff
(100 %id)
BM052732 Islets of Langerhans, Pancreas .j-u 1092 to 1561 470 to 1   fully sequenced,   470/470
(100 %)
3 diff
(99.4 %id)
AI682014 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j-u 1099 to 1555 470 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
AI803035 pooled .j-u 1100 to 1555 467 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 456/456
(100 %)
0 diff
(100 %id)
AI872122 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j-u 1105 to 1557 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AI160170 heart .j-u 1108 to 1555 460 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 448/448
(100 %)
0 diff
(100 %id)
AI888001 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j-u 1110 to 1555 459 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
AI149526 placenta .j-u 1111 to 1555 456 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 445/445
(100 %)
0 diff
(100 %id)
AI984576 malignant melanoma, metastatic to lymphnode, skin .j-u 1112 to 1560 468 to 20   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
AI954034 normal epithelium, ovary .j-u 1113 to 1555 458 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 443/443
(100 %)
0 diff
(100 %id)
AA548471 colon, tumor .j-u 1121 to 1555 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AA251232 germinal center B cell .j-u 1129 to 1555 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI090566 heart .j-u 1129 to 1555 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI190196 heart .j-u 1131 to 1555 442 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 425/425
(100 %)
0 diff
(100 %id)
AI015859   .j-u 1135 to 1560 443 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 426/426
(100 %)
0 diff
(100 %id)
AA486891 lung .j-u 1139 to 1561 423 to 1   fully sequenced,   423/423
(100 %)
0 diff
(100 %id)
AI989394 thymus, pooled .j-u 1144 to 1555 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AA053771 colon, tumor .j-u 1145 to 1301 1 to 167   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 167/167
(100 %)
0 diff
(100 %id)
AA486801 lung .j-u 1145 to 1555 1 to 409   fully sequenced,   409/409
(100 %)
2 diff
(99.6 %id)
AI470206 pooled .j-u 1146 to 1560 440 to 26   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 415/415
(100 %)
0 diff
(100 %id)
AA991198 2 pooled tumors (clear cell type), Kidney .j-u 1147 to 1560 424 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
AA664378 lung .j-u 1149 to 1560 412 to 1       412/412
(100 %)
0 diff
(100 %id)
W95398 heart .j-u 1157 to 1555 402 to 1   fully sequenced,   402/402
(100 %)
3 diff
(99.3 %id)
AA022549 heart .j-u 1162 to 1557 398 to 1       398/406
(98 %)
1 diff
(99.8 %id)
W88556 liver and spleen .j-u 1184 to 1555 372 to 1       372/372
(100 %)
0 diff
(100 %id)
AA532616 normal prostatic epithelial cells, Prostate .j-u 1202 to 1559 372 to 15   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 358/365
(98 %)
0 diff
(100 %id)
AA428587   .j-u 1206 to 1560 355 to 1   fully sequenced,   355/355
(100 %)
3 diff
(99.2 %id)
AA551725 normal prostatic epithelial cells, Prostate .j-u 1222 to 1560 352 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 339/339
(100 %)
0 diff
(100 %id)
AA074726   .j-u 1260 to 1556 299 to 1   fully sequenced,   299/299
(100 %)
0 diff
(100 %id)
AA053669 colon, tumor .j-u 1271 to 1555 327 to 42   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 286/286
(100 %)
1 diff
(99.7 %id)
AA487122 lung .j-u 1282 to 1554 273 to 1   fully sequenced,   273/273
(100 %)
0 diff
(100 %id)
FN066366 breast carcinoma .j-u 1302 to 1405 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
BF910232 uterus_tumor .j-u 1306 to 1496 199 to 9     Submitted on the opposite strand 191/199
(95 %)
0 diff
(100 %id)
BE940364 uterus_tumor .j-u 1308 to 1498 217 to 27       191/219
(87 %)
0 diff
(100 %id)
BF812916 colon_ins .j-u 1334 to 1557 237 to 16     Submitted on the opposite strand 222/247
(89 %)
0 diff
(100 %id)
BQ000368 Fibrosarcoma .j-u 1342 to 2104 776 to 19 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 758/758
(100 %)
5 diff
(99.4 %id)
BF837918 head_neck .j-u 1376 to 1564 209 to 24     Submitted on the opposite strand 186/209
(88 %)
0 diff
(100 %id)
BQ370155 placenta_normal .j-u 1376 to 1565 192 to 6       187/194
(96 %)
0 diff
(100 %id)
BG180801 adenocarcinoma, cell line, Prostate .j-u 1419 to 2107 1 to 687 exact     687/699
(98 %)
6 diff
(99.2 %id)
BE930075 placenta_normal .j-u 1425 to 1556 133 to 2       132/133
(99 %)
0 diff
(100 %id)
BQ632119 Pancreas, Purified pancreatic islet .j-u 1486 to 2103 618 to 1 exact     618/618
(100 %)
0 diff
(100 %id)
AW082208 pooled .j-u 1557 to 2105 549 to 1 exact tiling clone,   549/549
(100 %)
0 diff
(100 %id)
AI130971 heart .j-u 1567 to 2105 539 to 1 exact     539/539
(100 %)
0 diff
(100 %id)
AW778847 colon, moderately-differentiated adenocarcinoma .j-u 1577 to 2106 530 to 1 exact     530/530
(100 %)
0 diff
(100 %id)
AI384096 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 1600 to 2099 500 to 1 exact     500/500
(100 %)
0 diff
(100 %id)
AI689477 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j-u 1617 to 2104 488 to 1 exact     488/488
(100 %)
0 diff
(100 %id)
AI127759 uterus .j-u 1618 to 2099 482 to 1 exact     482/482
(100 %)
0 diff
(100 %id)
AI986215 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j-u 1651 to 2105 455 to 1 exact     455/455
(100 %)
0 diff
(100 %id)
F00396 leg muscle, skeletal muscle .j-u 1892 to 2072 181 to 1       181/181
(100 %)
0 diff
(100 %id)
F00413 leg muscle, skeletal muscle .j-u 1909 to 2074 166 to 1       166/166
(100 %)
0 diff
(100 %id)
TI_154100541   .k 1 to 826 887 to 69   tiling clone,   819/894
(91 %)
11 diff
(98.8 %id)
DA743435   .k 32 to 599 2 to 569   tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
BM149380 leukopheresis .k 574 to 934 41 to 401   tiling clone,   361/401
(90 %)
11 diff
(97.3 %id)
BF743168 breast Gene TUG1, variant not shown         Submitted on the opposite strand    
AW993026 breast_normal Gene TUG1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes D